The FDA is under assault for change in drug approval procedures.
One nominee for the FDA commissioner would like to see all drugs approved provided they are safe, but regardless of whether they work or not.
Unilife is uniquely positioned for this type of situation as all of their devises are capable of monitoring and transmitting compliance.
This is required by health insurance companies who at present are not accepting the high drug cost without proof that the drug works.
Unilife products have the capacity to provide proof of injecting compliance on all drugs including those in vials.
Flextronics is waiting in the wings with a massive capacity to manufacture Unilife's products.
USA has 50 million patients with auto immune disease.
It is of interest to understand the importance of these mounting pressures.
http://www.reuters.com/article/us-usa-trump-healthcare-regulation-analy-idUSKBN15U0GP
